National Drug Abuse Treatment 

 OREGON/HAWAII NODE


OREGON/HAWAII NODE

Dennis McCarty, Ph.D.
Principal Investigator

Department of Public Health and Preventive Medicine
Oregon Health and Science University
3181 SW Sam Jackson Park Rd., CB 669
Portland, OR 97239
mccartyd@ohsu.edu
http://www.ohsu.edu/public-health/
research/csapr_about.shtml
(Node)
http://www.nida.nih.gov/CTN/centers/oregon.html (NIDA)

The Oregon/Hawaii Node (formerly the "Oregon Node") joined the Clinical Trials Network in September 1999 and was renewed in 2005. This Node is a bi-directional clinical trial partnership of two research and training organizations -- Oregon Health & Science University (the Regional Research Training Center (RRTC)) with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii -- and eight multi-modality drug treatment programs located in urban and rural communities in Oregon, Hawaii, and Washington. These programs serve a growing number of Latino, Native American, Hawaiian, Russian, Asian, and female clients. Services are provided across the treatment continuum.


FIND IT!  Publications with Oregon/Hawaii involvement


OREGON/HAWAII NODE PROTOCOL INVOLVEMENT

  Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules

MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

HIV and HCV Intervention in Drug Treatment Settings

Job Seekers Training for Patients with Drug Dependence

Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

Starting Treatment with Agonist Replacement Therapies (START)

Attention Deficit Hyperactivity Disorder (ADHD) in Adult Smokers

Prescription Opioid Addiction Treatment Study (POATS)


Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

Organizational Characteristics that Influence the Adoption of Evidence-Based Practices

HIV Rapid Testing and Counseling

Methamphetamine Use Among American Indians

The Choctaw Nation Methamphetamine Data Needs Project

 


  

  

 

 

 

 




Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2008 -- http://ctndisseminationlibrary.org/nodes/ornode.htm
info@ctndisseminationlibrary.org